CEL-SCI Corp (CVM) Updates on FDA Partial Clinical Hold; Has Begun Working on Response

October 21, 2016 8:03 AM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

CEL-SCI Corporation (NYSE: CVM) announced : following up on our press release issued on September 26, 2016, we have received the Partial Clinical Hold letter from the U.S. Food and Drug Administration (FDA). CEL-SCI has started working on a response to the FDA and will work diligently with the FDA to seek to have the partial clinical hold lifted.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, Hot Corp. News, Trader Talk

Add Your Comment